A mutation in the pore region of HERG K+ channels expressed in Xenopus oocytes reduces rectification by shifting the voltage dependence of inactivation

The Journal of Physiology
A ZouM C Sanguinetti

Abstract

1. The effects of a mutation in the human ether-a-go-go-related gene (HERG) (Ser631 to Ala, S631A) on the voltage- and extracellular [K+] dependence of inactivation were studied in Xenopus oocytes using two microelectrode and single channel voltage-clamp techniques. 2. The voltage required for half-inactivation of S631A HERG was 102 mV more positive than for wild-type (WT)-HERG, resulting in reduced rectification of the steady-state current-voltage relationship. In contrast, the voltage dependence of channel activation was not altered by the S631A mutation. These findings indicate that inactivation of HERG channels is not linked to activation. 3. Rectification of whole-cell S631A HERG current was caused by a voltage-dependent reduction in open probability, and inward rectification of the current-voltage relationship of single channels. 4. Elevation of extracellular [K+] from 2 to 20 mM shifted the half-point for inactivation by +20 mV for WT-HERG, and +25 mV for S631A HERG. Thus, elevated [K+]o and the S631A mutation affect HERG inactivation by different mechanisms. 5. The S631A mutation altered the ion translocation rate of HERG channels. The single channel conductance (gamma) of S631A HERG was 20 pS between -40 and-100 mV, an...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L A PardoW Stühmer
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K L ChoiG Yellen
Jan 1, 1990·The Japanese Journal of Physiology·M HorieC Kawai
Dec 15, 1995·Circulation·M W VeldkampL N Bouman
May 1, 1996·The Journal of General Physiology·P S SpectorM C Sanguinetti

❮ Previous
Next ❯

Citations

May 28, 2008·Pflügers Archiv : European journal of physiology·Anders Peter LarsenThomas Jespersen
Oct 3, 2002·European Journal of Pharmacology·Anna P MalykhinaHamid I Akbarali
Mar 8, 2003·Journal of Molecular and Cellular Cardiology·Martin Tristani-Firouzi, Michael C Sanguinetti
Dec 21, 2010·Nature Structural & Molecular Biology·David T WangJamie I Vandenberg
Sep 14, 1999·British Journal of Pharmacology·H WangZ Wang
Oct 7, 2000·Clinical and Experimental Pharmacology & Physiology·H J Witchel, J C Hancox
Oct 3, 2002·The Journal of General Physiology·Franklin M MullinsJeffrey R Balser
Aug 30, 2012·The Journal of General Physiology·Vivek GargMichael C Sanguinetti
Aug 28, 2013·The Journal of General Physiology·Matthew D PerryJamie I Vandenberg
Oct 24, 2013·Assay and Drug Development Technologies·Haoyu ZengArmando Lagrutta
Mar 11, 2003·The Journal of Physiology·Shetuan ZhangDavid Fedida
Nov 15, 2005·Molecular Pharmacology·Oscar CasisMichael C Sanguinetti
Nov 3, 2011·Molecular Pharmacology·Adrienne T DennisEckhard Ficker
Aug 1, 2012·PloS One·David A KöpferUlrich Zachariae
Apr 12, 2003·The Japanese Journal of Physiology·Hirofumi ShimizuShigetoshi Oiki
Mar 19, 2014·The Journal of General Physiology·Wei WuMichael C Sanguinetti
Feb 13, 2001·Biochemical and Biophysical Research Communications·A A PaulJ C Hancox
Aug 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Matthew PerryMichael C Sanguinetti
Aug 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·David R PiperMartin Tristani-Firouzi
May 10, 2001·Journal of Molecular and Cellular Cardiology·G N Tseng
May 10, 2001·Journal of Molecular and Cellular Cardiology·J KurokawaR S Kass
Mar 9, 2013·The Journal of Biological Chemistry·Matthew D PerryJamie I Vandenberg
Mar 25, 2006·The Journal of Physiology·C E ClarkeJ I Vandenberg
Nov 2, 1999·The Journal of Physiology·A BarbutiD DiFrancesco
Feb 26, 2016·Biochimica Et Biophysica Acta·Valentin Sottas, Hugues Abriel
Feb 12, 2005·The Journal of Physiology·Patrick SturmChristiane K Bauer
Sep 2, 2009·Biophysical Journal·Frank S ChoveauGildas Loussouarn
Jul 30, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jiqing GuoHenry J Duff
Jul 14, 2005·Biochemical and Biophysical Research Communications·Mark J McPateJules C Hancox
Jul 23, 2011·Biochimica Et Biophysica Acta·Yi H ZhangJules C Hancox
Oct 13, 2011·Journal of Molecular and Cellular Cardiology·Aziza El HarchiJules C Hancox
Dec 7, 2010·Journal of Molecular and Cellular Cardiology·Yaxun SunGan-Xin Yan
Feb 15, 2007·Expert Opinion on Therapeutic Targets·Harry J Witchel
Jun 15, 2007·Biochemical Pharmacology·R S DuncanJ C Hancox
Nov 5, 1999·Biophysical Journal·J P JohnsonP B Bennett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.